Search Results

You searched for : PharmaNews  

A ₹100-Crore Question: Are GLP-1 Injections Becoming India’s New Lifeline?

The obesity epidemic is vast. The solutions are emerging. Science is evolving. And the market is expanding. The launch of Yurpeak is another step in ...
Dec 12

Mankind’s Bet on Women’s Health: The ₹797-Crore Investment That Could Redefine India’s Pharma Future

In an industry where innovation often hides behind profit margins, Mankind’s bet on women’s health stands out as both a strategic and ethical ...
Oct 16

Indian Innovation vs Western Monopolies: Lupin’s FDA Triumph Tells a Bigger Story

Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ...
Jun 03

Novartis India Limited signs exclusive sales and distribution agreement with Dr. Reddy’s Laboratories

...
Feb 14

Asymchem Acquires Snapdragon Chemistry

Latest Corporate News update ; Pharma...
Feb 14

Novo Nordisk announces completion of Dicerna Pharmaceuticals acquisition

Latest pharma news update...
Dec 30

Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain

Latest pharma news update...
Nov 03

Everest Medicines enters into agreement with Providence Therapeutics to advance mRNA vaccines and Therapies

Latest Pharma News Update...
Sep 16

Precision BioSciences and Tiziana Life Sciences announce exclusive license agreement to evaluate Foralumab

Latest pharma Update...
Sep 06

Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes

Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes...
Jul 29

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Fifth disease that Dupixent has demonstrated positive pivotal results....
Jul 29

Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee for the Treatment of Diabetes

Interchangeable Designation Allows Substitution at the Pharmacy Counter for Lantus Across the U.S. to Help Increase Access to Medicines for People Living with Diabetes...
Jul 29

Dupixent significantly improved itch and hives in patients with chronic spontaneous urticaria

Fifth disease that Dupixent has demonstrated positive pivotal results....
Jul 29

BioNTech to acquire Kite’s neoantigen TCR Cell Therapy R&D platform and manufacturing facility in Gaithersburg, MD

Pharma merger and acquisition news...
Jul 22

Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease

New solutions are needed for the six million people in the US affected by anaemia of chronic kidney disease....
Jul 17

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

...
Jul 17

Merck Announces U.S. FDA Approval of VAXNEUVANCE for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older

Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus....
Jul 17

Sanofi streamlines Consumer Healthcare portfolio in Latin America with divestiture of eight brands to Hypera Pharma

As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources ...
Jul 14

Lupin Launches Tavaborole Topical Solution in the United States

The product will be manufactured at Lupin’s facility in Pithampur, India...
Jul 14

Stallergenes Greer and ALYATEC announce collaboration in allergen immunotherapy

With this collaboration, Stallergenes Greer aims to strengthen its precision medicine-based approach ...
Jul 12

Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity

Pharma News update : Strategic Investments...
Jul 05

Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease

If approved, Forxiga has the potential to change the treatment paradigm for millions of people in the EU suffering from chronic kidney disease...
Jun 28

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG

2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ...
Jun 28

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy

Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-...
Jun 25

25 Matching result(s) found!

-Advertisements-




Trending Now

Sleep Health in India: Recognising the Public Health Impact of Sleep DisordersNovember 06, 2026
Childhood Hearing Screening: Linking Early Detection With Timely SupportNovember 06, 2026
Low-Dose Imaging in India: Accuracy Meets SafetyNovember 06, 2026
Synthetic Health Data: Powering the Future of Medical AINovember 06, 2026
AI and Clinical Trials: How ML Is Changing Patient RecruitmentNovember 05, 2026
Photon-Counting CT: What Indian Hospitals Need to KnowNovember 05, 2026
Rare Diseases in India: Navigating Diagnosis, Support and Long-Term CareNovember 05, 2026
Oral Health and Systemic Health: The Case for Routine Dental IntegrationNovember 05, 2026
KIMS Hospitals Takes Another Major Step Forward in Cancer Care with Advanced TrueBeam TechnologyNovember 04, 2026
SRM Medical College Hospital and Research Centre Hosts National Conference on Translational Regenerative Biology and Bioengineering – TRBB 2026November 04, 2026
15-Month-Old Russian Baby Avoids Lung Transplant Following Treatment at MGM HealthcareNovember 04, 2026
Why Diabetes Care Must Go Beyond Blood Sugar ControlNovember 04, 2026
Sri Sathya Sai Heart Hospital Successfully Organises Free Heart Camp, Screening for 550 Patients in Dehradun, UttarakhandNovember 04, 2026
Expert Quote | Rising Air Pollution in Delhi | Agilus DiagnosticsNovember 04, 2026
Healthcare AI Safety Officers: India's New Leadership NeedNovember 04, 2026
Next-Generation Medical Imaging: Beyond Traditional ScansNovember 04, 2026
Menopause Care in India: Building Awareness Beyond Reproductive YearsNovember 04, 2026
Endometriosis in India: Why Diagnosis and Care Coordination MatterNovember 04, 2026
Newborn Screening in India: What Families Should Know About Early TestsNovember 03, 2026
Organ Donation in India: How the Transplant Coordination Journey WorksNovember 03, 2026